113 related articles for article (PubMed ID: 37759102)
41. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
[TBL] [Abstract][Full Text] [Related]
42. Post-menopausal oestrogen deficiency induces osteoblast apoptosis via regulating HOTAIR/miRNA-138 signalling and suppressing TIMP1 expression.
Xu SY; Shi P; Zhou RM
J Cell Mol Med; 2021 May; 25(10):4572-4582. PubMed ID: 33733597
[TBL] [Abstract][Full Text] [Related]
43. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
[TBL] [Abstract][Full Text] [Related]
44. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
[TBL] [Abstract][Full Text] [Related]
45. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
46. Identification of TIMP1 as an inflammatory biomarker associated with temporal lobe epilepsy based on integrated bioinformatics and experimental analyses.
He Y; Zhang H; Ma L; Li J; Wang F; Zhou H; Zhang G; Wen Y
J Neuroinflammation; 2023 Jun; 20(1):151. PubMed ID: 37365625
[TBL] [Abstract][Full Text] [Related]
47. Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study.
Neuhaus J; Schiffer E; Mannello F; Horn LC; Ganzer R; Stolzenburg JU
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28471417
[TBL] [Abstract][Full Text] [Related]
48. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.
Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; Rodríguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A
Br J Cancer; 2011 Nov; 105(10):1608-14. PubMed ID: 22067904
[TBL] [Abstract][Full Text] [Related]
50. TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer.
Yang L; Jiang Q; Li DZ; Zhou X; Yu DS; Zhong J
Aging (Albany NY); 2019 Oct; 11(20):8998-9012. PubMed ID: 31639773
[TBL] [Abstract][Full Text] [Related]
51. Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction.
Takawale A; Zhang P; Patel VB; Wang X; Oudit G; Kassiri Z
Hypertension; 2017 Jun; 69(6):1092-1103. PubMed ID: 28373589
[TBL] [Abstract][Full Text] [Related]
52. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
[TBL] [Abstract][Full Text] [Related]
53. ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells.
Botta GP; Reichert M; Reginato MJ; Heeg S; Rustgi AK; Lelkes PI
Neoplasia; 2013 Apr; 15(4):359-72. PubMed ID: 23555182
[TBL] [Abstract][Full Text] [Related]
54. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract][Full Text] [Related]
55. miR-6745-TIMP1 axis inhibits cell growth and metastasis in gastric cancer.
Liu H; Xiang Y; Zong QB; Zhang XY; Wang ZW; Fang SQ; Zhang TC; Liao XH
Aging (Albany NY); 2021 Nov; 13(21):24402-24416. PubMed ID: 34775375
[TBL] [Abstract][Full Text] [Related]
56. TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer.
Omar OM; Soutto M; Bhat NS; Bhat AA; Lu H; Chen Z; El-Rifai W
Mol Carcinog; 2018 Nov; 57(11):1577-1587. PubMed ID: 30035371
[TBL] [Abstract][Full Text] [Related]
57. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
[TBL] [Abstract][Full Text] [Related]
58. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
[TBL] [Abstract][Full Text] [Related]
59. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
[TBL] [Abstract][Full Text] [Related]
60. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]